The following table sets forth the computation of the Company’s net income per share:


	Three Months Ended						Six Months Ended
	December 31,			January 1,			December 31,			January 1,
	2023			2023			2023			2023
Net income from continuing operations	$	5,927		$	19,983		$	13,003		$	44,618
Loss from discontinued operations, net of tax		(41	)		(300	)		(922	)		(20,867	)
Net income	$	5,886		$	19,683		$	12,081		$	23,751

Weighted average shares — basic		17,010,116			17,669,645			17,083,204			17,807,853
Dilutive effect of assumed exercises of stock options		—			8,175			—			8,134
Dilutive effect of assumed restricted share awards/units		81,517			96,509			74,920			87,040
Weighted average outstanding shares — diluted		17,091,633			17,774,329			17,158,124			17,903,027
Basic net income (loss) per share
Continuing operations	$	0.35		$	1.13		$	0.76		$	2.51
Discontinued operations	$	—		$	(0.02	)		(0.05	)		(1.18	)
Net income	$	0.35		$	1.11		$	0.71		$	1.33
Diluted net income (loss) per share
Continuing operations	$	0.35		$	1.12		$	0.76		$	2.49
Discontinued operations	$	(0.01	)	$	(0.01	)		(0.06	)		(1.16	)
Net income	$	0.34		$	1.11		$	0.70		$	1.33

For the three and six months ended December 31, 2023 and January 1, 2023, an immaterial number of shares were excluded from the computation of diluted earnings per share as the effect would have been anti-dilutive.

On June 24, 2021, the board of directors of the Company authorized a share repurchase program that allowed for the repurchase of up to $50.0 million of the Company’s common stock during the three-year period ending June 24, 2024. While having $1.6 million of availability as of June 30, 2023, this program was fully utilized during the first quarter ended October 1, 2023.

On July 24, 2023, the board of directors of the Company authorized a new share repurchase program under which the Company may repurchase up to $50.0 million of its outstanding shares of common stock. The new authorization became effective upon the completion of the Company's existing $50.0 million stock repurchase authorization.

During the three months ended December 31, 2023 and January 1, 2023, the Company repurchased 214,219 shares and 224,284 shares of common stock for $4.4 million and $4.8 million, respectively, in cash, excluding related fees and expenses. During the six months ended December 31, 2023 and January 1, 2023, the Company repurchased 455,983 shares and 415,644 shares of common stock for $10.2 million and $9.0 million, respectively, in cash, excluding related fees and expenses. As of December 31, 2023, $41.5 million remained available under the program.